ACADIA Pharmaceuticals Stock (NASDAQ: ACAD) stock price, news, charts, stock research, profile.
Open | $16.500 |
Close | $16.310 |
Volume / Avg. | 1.661M / 1.797M |
Day Range | 16.160 - 16.510 |
52 Wk Range | 16.550 - 33.990 |
Market Cap | $2.697B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 27 |
Short Interest | 9.08% |
Days to Cover | 6.54 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ACADIA Pharmaceuticals (NASDAQ: ACAD) through any online brokerage.
Other companies in ACADIA Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX) and TG Therapeutics (NASDAQ:TGTX).
The latest price target for ACADIA Pharmaceuticals (NASDAQ: ACAD) was reported by Cantor Fitzgerald on Wednesday, April 10, 2024. The analyst firm set a price target for 37.00 expecting ACAD to rise to within 12 months (a possible 126.02% upside). 63 analyst firms have reported ratings in the last year.
The stock price for ACADIA Pharmaceuticals (NASDAQ: ACAD) is $16.37 last updated April 25, 2024 at 6:10 PM EDT.
There are no upcoming dividends for ACADIA Pharmaceuticals.
ACADIA Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for ACADIA Pharmaceuticals.
ACADIA Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.